Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chung-Ping Yu, Hui-Ju Lin, Shiuan-Pey Lin, Chi-Sheng Shia, Pei-Hua Chang, Yu-Chi Hou & Yo-Wen Hsieh. (2016) Rhubarb decreased the systemic exposure of cyclosporine, a probe substrate of P-glycoprotein and CYP 3A. Xenobiotica 46:8, pages 677-682.
Read now
Read now
Xinchi Feng, Liqin Ding & Feng Qiu. (2015) Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid. Drug Metabolism Reviews 47:2, pages 229-238.
Read now
Read now
Gino A. Vena, Antonia Galluccio, Michele Pezza, Michelangelo Vestita & Nicoletta Cassano. (2012) Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study. Journal of Dermatological Treatment 23:4, pages 255-260.
Read now
Read now
Articles from other publishers (40)
Maurice Moelleken, Britta Kießler, Eva Hadaschik & Joachim Dissemond. (2022) Successful therapy of ulcerative morphea with topical application of pimecrolimus. Journal of the European Academy of Dermatology and Venereology 37:3.
Crossref
Crossref
Lisa A. O'Higgins, Karen Eustace & Anne‐Marie Tobin. (2022) Fortuitous discoveries in dermatology. Journal of the European Academy of Dermatology and Venereology 37:2, pages 226-230.
Crossref
Crossref
Iago Gonçalves Ferreira, Magda Blessmann Weber & Renan Rangel Bonamigo. 2023. Dermatology in Public Health Environments. Dermatology in Public Health Environments
2105
2155
.
Sonia Trombino, Camilla Servidio, Annarita Stella Laganà, Filomena Conforti, Mariangela Marrelli & Roberta Cassano. (2020) Viscosified Solid Lipidic Nanoparticles Based on Naringenin and Linolenic Acid for the Release of Cyclosporine A on the Skin. Molecules 25:15, pages 3535.
Crossref
Crossref
Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn M.R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Dario Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Robert S. Rahimi, Reena N. Rupani, Michael Siegel, Benjamin Stoff, Bruce E. Strober, Elliot B. Tapper, Emily B. Wong, Jashin J. Wu, Vidhya Hariharan & Craig A. Elmets. (2020) Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. Journal of the American Academy of Dermatology 82:6, pages 1445-1486.
Crossref
Crossref
J. Berth‐Jones, L.S. Exton, E. Ladoyanni, M.F. Mohd Mustapa, V.M. Tebbs, P.D. Yesudian, N.J. Levell, P.M. McHenry, T.A. Leslie, S. Wakelin, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, N. Chiang, F.S. Worsnop, A. Salim, D. Buckley, G. Petrof, N. Callachand, T. Flavell & A.A. Salad. (2019) British Association of Dermatologists guidelines for the safe and effective prescribing of oral ciclosporin in dermatology 2018. British Journal of Dermatology 180:6, pages 1312-1338.
Crossref
Crossref
Sonia Trombino, Rossella Russo, Silvia Mellace, Giuseppe Pasquale Varano, Annarita Stella Laganà, Fabio Marcucci & Roberta Cassano. (2019) Solid lipid nanoparticles made of trehalose monooleate for cyclosporin-A topic release. Journal of Drug Delivery Science and Technology 49, pages 563-569.
Crossref
Crossref
Bo Ri KimSeungkeol YangEun Jin DohChong Won ChoiSang Woong Youn. (2018) Risk Factors Affecting Adverse Effects of Cyclosporine A in a Real-World Psoriasis Treatment. Annals of Dermatology 30:2, pages 143.
Crossref
Crossref
Feng-Yang Chen, Li-Fei Zhou, Xiao-Yu Li, Shi-Fang Xu, Li-Juan Gao, Hong-Xiang Sun & Yi-Ping Ye. (2017) Stephanthraniline A and Cyclosporine A Synergize to Inhibit T-cell Response in vitro and in vivo. International Journal of Pharmacology 13:3, pages 266-273.
Crossref
Crossref
Janna M. Vassantachart & Sharon E. Jacob. (2017) Cyclosporine in the Treatment of Psoriasis. Journal of the Dermatology Nurses? Association 9:2, pages 98-101.
Crossref
Crossref
Surbhi Dubey, Rajeev Sharma, Nishi Mody & Suresh P. Vyas. 2017. Nanostructures for Novel Therapy. Nanostructures for Novel Therapy
657
684
.
Inês Raposo & Tiago Torres. (2016) Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects. American Journal of Clinical Dermatology 17:4, pages 349-358.
Crossref
Crossref
Zhenying Zhang, Zhen Yu, Pan Tian, Suchun Hou, Shixin Han, Xuejing Tan, Yongjun Piao & Xiaoming Liu. (2014) Differentially‑expressed genes identified by suppression subtractive hybridization in the bone marrow hematopoietic stem cells of patients with psoriasis. Molecular Medicine Reports.
Crossref
Crossref
Yury V. Shebzukhov, Katharina Horn, Kristina I. Brazhnik, Marina S. Drutskaya, Anna A. Kuchmiy, Dmitry V. Kuprash & Sergei A. Nedospasov. (2014) Dynamic changes in chromatin conformation at the TNF transcription start site in T helper lymphocyte subsets. European Journal of Immunology 44:1, pages 251-264.
Crossref
Crossref
Madhulika Pradhan, Deependra Singh & Manju Rawat Singh. (2013) Novel colloidal carriers for psoriasis: Current issues, mechanistic insight and novel delivery approaches. Journal of Controlled Release 170:3, pages 380-395.
Crossref
Crossref
Semsettin Karaca, Fatma Fidan, Faruk Erkan, Serkan Nural, Tulay Pinarc?Ersin Gunay & Mehmet Unlu. (2012) Might psoriasis be a risk factor for obstructive sleep apnea syndrome?. Sleep and Breathing 17:1, pages 275-280.
Crossref
Crossref
Marina Frušić‐Zlotkin, Yoram Soroka, Ran Tivony, Liraz Larush, Lilian Verkhovsky, François Menahem Brégégère, Rami Neuman, Shlomo Magdassi & Yoram Milner. (2012)
Penetration and biological effects of topically applied cyclosporin
A
nanoparticles in a human skin organ culture inflammatory model
. Experimental Dermatology 21:12, pages 938-943.
Crossref
Crossref
Yu-Chi Hou, Shiuan-Pey Lin & Pei-Dawn Lee Chao. (2012) Liquorice reduced cyclosporine bioavailability by activating P-glycoprotein and CYP 3A. Food Chemistry 135:4, pages 2307-2312.
Crossref
Crossref
M. David, L. Akerman, M. Ziv, M. Kadurina, D. Gospodinov, F. Pavlotsky, R. Yankova, V. Kouzeva, M. Ramon, M.H. Silverman & P. Fishman. (2012) Treatment of plaque-type psoriasis with oral CF101: data from an exploratory randomized phase 2 clinical trial. Journal of the European Academy of Dermatology and Venereology 26:3, pages 361-367.
Crossref
Crossref
Theresa Hautz, Dolores Wolfram, Johanna Grahammer, Ravi Starzl, Christoph Krapf, Johann Pratschke, W. P. Andrew Lee, Gerald Brandacher & Stefan Schneeberger. (2012) Mechanisms and Mediators of Inflammation: Potential Models for Skin Rejection and Targeted Therapy in Vascularized Composite Allotransplantation. Clinical and Developmental Immunology 2012, pages 1-9.
Crossref
Crossref
Mohamed M. Osman, Dzenan Lulic, Loren Glover, Christine E. Stahl, Tsz Lau, Harry van Loveren & Cesar V. Borlongan. (2011) Cyclosporine-A as a neuroprotective agent against stroke: Its translation from laboratory research to clinical application. Neuropeptides 45:6, pages 359-368.
Crossref
Crossref
Delia Colombo & Susanna Poggi. (2011) Clinical profile of cyclosporine in dermatology. Drug Development Research 72:7, pages 634-646.
Crossref
Crossref
Douglas O. Sobel, Annette Henzke & Val Abbassi. (2010) Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus. Acta Diabetologica 47:3, pages 243-250.
Crossref
Crossref
Kaiming Zhang, Xinhua Li, Guohua Yin, Yufeng Liu & Xuyuan Tang. (2009) Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34+ cells of psoriatic patients with family history. Experimental Dermatology 19:8, pages e128-e135.
Crossref
Crossref
Michelle E.A. de Jager, Elke M.G.J. de Jong, Peter C.M. van de Kerkhof & Marieke M.B. Seyger. (2010) Efficacy and safety of treatments for childhood psoriasis: A systematic literature review. Journal of the American Academy of Dermatology 62:6, pages 1013-1030.
Crossref
Crossref
David M. Rosmarin, Mark Lebwohl, Boni E. Elewski & Alice B. Gottlieb. (2010) Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. Journal of the American Academy of Dermatology 62:5, pages 838-853.
Crossref
Crossref
S. M. Breathnach. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
177
.
S. M. Breathnach, C. H. Smith, R. J. G. Chalmers & R. J. Hay. 2010. Rook's Textbook of Dermatology. Rook's Textbook of Dermatology
1
53
.
Monique Kamaria, Wilson Liao & John Koo. (2018) A Practical Approach to the Use of Cyclosporine for the Treatment of Psoriasis. Psoriasis Forum 16a:1, pages 49-58.
Crossref
Crossref
Eun Ju LeeMin Kyung ShinNack In Kim. (2010) A Clinical Trial of Combination Therapy with Etanercept and Low Dose Cyclosporine for the Treatment of Refractory Psoriasis. Annals of Dermatology 22:2, pages 138.
Crossref
Crossref
Silvia Moretti, Francesca Prignano & Torello Lotti. 2010. Pruritus. Pruritus
307
310
.
Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, John Y.M. Koo, Mark Lebwohl, Henry W. Lim, Abby S. Van Voorhees, Karl R. Beutner & Reva Bhushan. (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology 61:3, pages 451-485.
Crossref
Crossref
Thais Jerez Jaime, Beatriz Alessi Rodrigues, Tatiana Jerez Jaime, Maria Lourdes Peris Barbo & Deborah Regina Cunha Simis. (2009) Psor?ase de von Zumbusch. Anais Brasileiros de Dermatologia 84:3, pages 209-301.
Crossref
Crossref
A.B. Alexandroff, M. Pauriah, R.D.R. Camp, C.C. Lang, A.D. Struthers & D.J. Armstrong. (2009) More than skin deep: atherosclerosis as a systemic manifestation of psoriasis. British Journal of Dermatology 161:1, pages 1-7.
Crossref
Crossref
Andrew J. Olaharski, Hirdesh Uppal, Matthew Cooper, Stefan Platz, Tanja S. Zabka & Kyle L. Kolaja. (2009) In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates. Toxicology Letters 188:2, pages 98-103.
Crossref
Crossref
Masaaki KATAYAMA, Hiroyuki IGARASHI, Kenji TANI, Yoshinori NEZU, Yasuji HARADA, Takuya YOGO, Yasushi HARA, Shinobu AOKI & Masahiro TAGAWA. (2008) Effect of Multiple Oral Dosing of Fluconazole on the Pharmacokinetics of Cyclosporine in Healthy Beagles. Journal of Veterinary Medical Science 70:1, pages 85-88.
Crossref
Crossref
Edward M. Prodanovic & Neil J. Korman. 2008. Treatment of Psoriasis. Treatment of Psoriasis
103
120
.
K. Zhang, R. Zhang, X. Li, G. Yin, X. Niu & R. Hou. (2007) The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clinical and Experimental Dermatology 32:6, pages 702-708.
Crossref
Crossref
R.K. Wali, V. Mohanlal, E. Ramos, S. Blahut, C. Drachenberg, J. Papadimitriou, M. Dinits, A. Joshi, B. Philosophe, C. Foster, C. Cangro, J. Nogueira, M. Cooper, S.T. Bartlett & M.R. Weir. (2007) Early Withdrawal of Calcineurin Inhibitors and Rescue Immunosuppression with Sirolimus-Based Therapy in Renal Transplant Recipients with Moderate to Severe Renal Dysfunction. American Journal of Transplantation 7:6, pages 1572-1583.
Crossref
Crossref
Jörg C. Prinz. 2007. Fortschritte der praktischen Dermatologie und Venerologie 2006. Fortschritte der praktischen Dermatologie und Venerologie 2006
60
63
.